United Kingdom - Scotland Renal Registry Renal Replacement Therapy Data 2021 - ERA-EDTA
GHDx Entry last modified on: Aug 15, 2024
Prevalence
Dataset Records for Prevalence
Displaying 51 - 100 of 5081
Spain - Andalusia Renal Registry Renal Replacement Therapy Data 2021 - ERA-EDTA
GHDx Entry last modified on: Aug 15, 2024
Kosovo Renal Registry Renal Replacement Therapy Data 2021 - ERA-EDTA
GHDx Entry last modified on: Aug 15, 2024
Brazil - São Paulo Household Survey to Estimate the Seroprevalence of SARS-CoV-2 Infection, 2021, Phase 5 (SoroEpi MSP)
Avaliação da prevalência da infecção pelo vírus SARS-CoV-2 em habitantes do município de São Paulo: Resultados Parciais da Fase 5
Hidden fraction of Polish population immune to SARS-CoV-2 in May 2021. Preprint
GHDx Entry last modified on: Mar 14, 2022
Switzerland Renal Registry Renal Replacement Therapy Data 2021 - ERA-EDTA
GHDx Entry last modified on: Aug 15, 2024
Spain - Extremadura Renal Registry Renal Replacement Therapy Data 2021 - ERA-EDTA
GHDx Entry last modified on: Aug 15, 2024
Latvia Renal Registry Renal Replacement Therapy Data 2021 - ERA-EDTA
GHDx Entry last modified on: Aug 15, 2024
Sweden Renal Registry Renal Replacement Therapy Data 2021 - ERA-EDTA
GHDx Entry last modified on: Aug 15, 2024
Spain - Castille-Leon Renal Registry Renal Replacement Therapy Data 2021 - ERA-EDTA
GHDx Entry last modified on: Aug 15, 2024
Albania Renal Registry Renal Replacement Therapy Data 2021 - ERA-EDTA
GHDx Entry last modified on: Aug 15, 2024
United Kingdom - England Renal Registry Renal Replacement Therapy Data 2021 - ERA-EDTA
GHDx Entry last modified on: Aug 15, 2024
France Renal Registry Renal Replacement Therapy Data 2021 - ERA-EDTA
GHDx Entry last modified on: Aug 15, 2024
Croatia Renal Registry Renal Replacement Therapy Data 2021 - ERA-EDTA
GHDx Entry last modified on: Aug 15, 2024
Sri Lanka STEPS Noncommunicable Disease Risk Factors Survey 2021
Survey:
Cross-sectional - Household - Interview - Nationally representative
Neuroepidemiology study of headache in the region of Jammu of north Indian population: A cross-sectional study
GHDx Entry last modified on: Mar 22, 2024
Austria Renal Registry Renal Replacement Therapy Data 2021 - ERA-EDTA
GHDx Entry last modified on: Aug 15, 2024
Spain - Navarra Renal Registry Renal Replacement Therapy Data 2021 - ERA-EDTA
GHDx Entry last modified on: Aug 15, 2024
Israel Renal Registry Renal Replacement Therapy Data 2021 - ERA-EDTA
GHDx Entry last modified on: Aug 15, 2024
Chronic Migraine Epidemiology and Outcomes - International (CaMEO-I) Study: Methods and multi-country baseline findings for diagnosis rates and care
GHDx Entry last modified on: Mar 22, 2024
Norway Renal Registry Renal Replacement Therapy Data 2021 - ERA-EDTA
GHDx Entry last modified on: Aug 15, 2024
Spain - Murcia Renal Registry Renal Replacement Therapy Data 2021 - ERA-EDTA
GHDx Entry last modified on: Aug 15, 2024
Slovakia Renal Registry Renal Replacement Therapy Data 2021 - ERA-EDTA
GHDx Entry last modified on: Aug 15, 2024
Serological prevalence of SARS-CoV-2 antibody among children and young age (between age 2-17 years) group in India: An interim result from a large multi-centric population-based seroepidemiological study. Preprint
GHDx Entry last modified on: Apr 8, 2022
United Kingdom - Wales Renal Registry Renal Replacement Therapy Data 2021 - ERA-EDTA
GHDx Entry last modified on: Aug 15, 2024
Greece Renal Registry Renal Replacement Therapy Data 2021 - ERA-EDTA
GHDx Entry last modified on: Aug 15, 2024
North Macedonia Renal Registry Renal Replacement Therapy Data 2021 - ERA-EDTA
GHDx Entry last modified on: Aug 15, 2024
Questionnaire-Based Survey during COVID-19 Vaccination on the Prevalence of Elderly's Migraine, Chronic Daily Headache, and Medication-Overuse Headache in One Japanese City-Itoigawa Hisui Study
GHDx Entry last modified on: Mar 22, 2024
Netherlands Renal Registry Renal Replacement Therapy Data 2021 - ERA-EDTA
GHDx Entry last modified on: Aug 15, 2024
Spain - Asturias Renal Registry Renal Replacement Therapy Data 2021 - ERA-EDTA
GHDx Entry last modified on: Aug 15, 2024
Lithuania Renal Registry Renal Replacement Therapy Data 2021 - ERA-EDTA
GHDx Entry last modified on: Aug 15, 2024
Seroprevalence of SARS-CoV-2 infection in the Colombo Municipality region, Sri Lanka. Preprint
GHDx Entry last modified on: Mar 14, 2022
United Kingdom - Northern Ireland Renal Registry Renal Replacement Therapy Data 2021 - ERA-EDTA
GHDx Entry last modified on: Aug 15, 2024
Spain - Aragon Renal Registry Renal Replacement Therapy Data 2021 - ERA-EDTA
GHDx Entry last modified on: Aug 15, 2024
Hungary Renal Registry Renal Replacement Therapy Data 2021 - ERA-EDTA
GHDx Entry last modified on: Aug 15, 2024
Prevalence of SARS-CoV-2 antibodies in Denmark 2020: results from nationwide, population-based sero-epidemiological surveys. Preprint
GHDx Entry last modified on: May 12, 2022
South Africa COVID-19 Special Public Health Surveillance Bulletin, Volume 18 Supplementary Issue 9, 12 March 2021
COVID-19 Special Public Health Surveillance Bulletin Volume 18 (Issue 9: 12 Mar 2021)
Epi surveillance:
Cross-sectional - Individual
Malawi Standardized Monitoring and Assessment of Relief and Transitions Nutrition Survey Round 7 2020
Malawi Round Seven SMART Nutrition Survey 2020
Survey:
Cross-sectional - Household
Serum-epidemiological Survey of SARS-CoV-2, Cities of Xai-Xai and Chókwè (InCOVID 2020) - Preliminary Results
Inquérito Sero-epidemiológico de SARS-CoV-2 nas Cidades de Xai-Xai e Chókwè (InCOVID 2020) - Resultados Preliminares -
Puerto Rico Community Assessment for Response to Public Health Emergencies (CASPER) 2020
Evaluación Comunitaria para la Respuesta a Emergencias de Salud Pública (CASPER)
Survey:
Epi surveillance
33.98% of Tripura has COVID-19 antibody in them, shows sero survey
Survey:
Epi surveillance
Seroprevalence of antibodies against SARS-CoV-2 virus in the adult Norwegian population, winter 2020/2021: pre-vaccination period. Preprint
GHDx Entry last modified on: May 12, 2022
Brazil - Maranhão Prevalence of SARS-CoV-2 Virus Infection Survey 2020 Phase II
Prevalência de infecção pelo vírus SARS-CoV-2 no Maranhão, segunda fase
Survey:
Individual - Interview
4.7% of the Austrian population had antibodies against SARS-CoV -2 in mid / late October
GHDx Entry last modified on: May 12, 2022
Brazil - Sao Paulo Household Survey to Estimate the Seroprevalence of SARS-CoV-2 Infection, 2020, Phase 4 (SoroEpi MSP)
Avaliação da prevalência da infecção pelo vírus SARS-CoV-2 em habitantes do município de São Paulo: Resultados Parciais da Fase 4
Serum-epidemiological Survey of SARS-CoV-2, City of Lichinga (InCOVID 2020) - Preliminary Results
Inquérito Sero-epidemiológico de SARS-CoV-2 nas Cidades de Lichinga (InCOVID 2020) - Resultados Preliminares -
Serum-epidemiological Survey of SARS-CoV-2, City of Beira (InCOVID 2020) - Preliminary Results
Inquérito Sero-epidemiológico de SARS-CoV-2 nas Cidades de Beira (InCOVID 2020) - Resultados Preliminares -
Serum-epidemiological Survey of SARS-CoV-2, City of Tete (InCOVID 2020) - Preliminary Results
Inquérito Sero-epidemiológico de SARS-CoV-2 nas Cidades de Tete (InCOVID 2020) - Resultados Preliminares -
Seroprevalence of SARS-CoV-2 Infection Among Occupational Groups from Bucaramanga Metropolitan Area, Colombia. Preprint
GHDx Entry last modified on: Oct 5, 2022
Andhra Pradesh Sero Survey Show Nearly 20% of State’s Population Exposed to Covid-19
Survey:
Cross-sectional - Epi surveillance - Urban only
Subscribe